Understanding Unmet Needs In Bladder Cancer In The Immunotherapy Era
Welcome to our comprehensive guide on Unmet Needs In Bladder Cancer In The Immunotherapy Era. Despite there now being a variety of promising immunotherapies for
Key Takeaways about Unmet Needs In Bladder Cancer In The Immunotherapy Era
- Aristotelis Bamias, MD, National and Kapodistrian University of Athens, Athens, Greece, talks on key
- Chong Xian Pan, MD, PhD, Harvard Medical School, Boston, MA, discusses improving the efficacy of
- Sushma Agrawal, MD, SGPGI, Lucknow, India, comments on the
- Leonard G. Gomella, MD, FACS, reviews the basic scientific concepts of
- Kyle M. Rose, MD, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, talks on key
Detailed Analysis of Unmet Needs In Bladder Cancer In The Immunotherapy Era
Prantik Das, MBBS, MRCP, FRCR, PG Dip, UHDB NHS Foundation Trust, Derby, UK and University of Nottingham, Nottingham, ... Eva Compérat, MD, PhD, Hôpital Tenon and Sorbonne University, Paris, France, outlines remaining challenges in the treatment ... Arlene Siefker-Radtke, MD, The University of Texas MD Anderson
Dr. Wright on Unmet Needs in Muscle-Invasive Bladder Cancer
In summary, understanding Unmet Needs In Bladder Cancer In The Immunotherapy Era gives us a better perspective.